TrialThe Lancet. Oncology2014

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

James W Denham et al.PubMed ↗Publisher ↗

No numbers read from the abstract.